Zobrazeno 1 - 10
of 322
pro vyhledávání: '"L, Bogliolo"'
Autor:
E. Marasco, M. Mussa, F. Motta, F. Bobbio-Pallavicini, R. Maserati, C. Montecucco, L. Bogliolo
Publikováno v:
Reumatismo, Vol 73, Iss 1 (2021)
The prevalence of osteoporosis is about three times greater in people living with HIV than in the general population. Bisphosphonates are the only class of antiresorptive drugs which have proved to be safe and effective in HIV patients. However, bisp
Externí odkaz:
https://doaj.org/article/291dbbdac3504394b0ac07b678166e27
Autor:
C. Caffetti, L. Bogliolo, G. Giuffrè, A. Sozzi, L. Degli Esposti, E. Bellis, C. Montecucco, F. Reitano, A. Triarico, S. Silva, M. Bejor, A. Muzzi, P. Mirabile, N. Ramaioli, M. Brait
Publikováno v:
Reumatismo, Vol 72, Iss 2 (2020)
The aim of this study was to promote the construction of a real network and a shared diagnostic and therapeutic management model between hospitals and out-of-hospital healthcare services to capture as many patients with bone fragility as possible. St
Externí odkaz:
https://doaj.org/article/10e4a5aa17c34bacb9e32edadb7b4ad6
Autor:
M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti
Publikováno v:
Reumatismo, Vol 69, Iss 1, Pp 30-39 (2017)
Osteoporosis and fractures are common and invalidating consequences of chronic glucorticoid (GC) treatment. Reliable information regarding the epidemiology of GC induced osteoporosis (GIOP) comes exclusively from the placebo group of randomized clini
Externí odkaz:
https://doaj.org/article/f717f6764b0642069eeb137985402106
Publikováno v:
Reumatismo, Vol 68, Iss 3, Pp 117-125 (2016)
Rheumatoid arthritis (RA) is a chronic immune-inflammatory disease associated with significant bone damage. Pathological bone remodeling in RA is primarily driven by persistent inflammation. Indeed, pro-inflammatory cytokines stimulate the differenti
Externí odkaz:
https://doaj.org/article/23d7b0bb1f074b998c00c758f5fd0c84
Publikováno v:
Reumatismo, Vol 65, Iss 3, Pp 138-141 (2013)
Diffuse alveolar hemorrhage (DAH) is a rare life-threatening condition which refers to the presence of red blood cells within alveoli deriving from hemorrhage originating in the pulmonary microvasculature. It differs from alveolar filling, in which b
Externí odkaz:
https://doaj.org/article/b56cc5cbe0ba4616bc5b29bbe2005577
Publikováno v:
Reumatismo, Vol 64, Iss 2, Pp 88-98 (2012)
In rheumatic diseases, biomarkers may serve as surrogate endpoints for diagnosis, prognosis, disease activity, therapeutic response and disease outcome. In recent years a great effort has been made to identify useful tools to establish early diagnosi
Externí odkaz:
https://doaj.org/article/e5397c106fc54d91a74c15467bffdb02
Autor:
P. Delvino, S. Monti, G. P. Grieco, E. Bozzalla Cassione, G. Franchi, L. Bogliolo, C. Montecucco
Publikováno v:
Annals of the Rheumatic Diseases. 81:1434.2-1435
BackgroundThe advent of effective immunosuppressive treatments significantly improved the prognosis of ANCA-associated vasculitides (AAV), which have become chronic relapsing diseases. Patients with inflammatory rheumatic disorders are particularly p
Autor:
V. Satta, L. Bogliolo, A. Borini, G. Coticchio, S. Succu, S. Ledda, F. Berlinguer, G.G. Leoni, S. Naitana
Publikováno v:
Journal of Biological Research, Vol 83, Iss 1 (2010)
Externí odkaz:
https://doaj.org/article/9b7b0d45af024d0382d3625b6c581d11
Autor:
L. Scudeller, Teresa Rampino, Pasquale Esposito, A. Giacomoni, L. Bogliolo, Giuseppe Sileno, Marilena Gregorini, Massimo Abelli, Maria Antonietta Grignano, Eleonora Francesca Pattonieri, Elena Ticozzelli, Valeria Corradetti
Publikováno v:
Transplantation Proceedings. 49:650-657
Kidney transplantation (KT) immunosuppression may induce bone tissue damage with bone mineral density (BMD) loss increasing bone fractures risk. Steroid therapy is considered the major player, but others factors are still under review.We designed an
Publikováno v:
Annals of the Rheumatic Diseases. 79:27-28
Background:Anti-citrullinated protein antibodies (ACPA) are a major risk factor for local and systemic bone loss in patients with rheumatoid arthritis (RA). We previously demonstrated that early RA patients at disease presentation already show reduce